Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy ; volume:43 ; number:4 ; day:15 ; month:2 ; year:2024 ; pages:723-734 ; date:4.2024
European journal of clinical microbiology & infectious diseases ; 43, Heft 4 (15.2.2024), 723-734, 4.2024
- Creator
-
Feuth, Eeva
Nieminen, Valtteri
Palomäki, Antti
Ranti, Juha
Sucksdorff, Marcus
Finnilä, Taru
Oksi, Jarmo
Vuorinen, Tytti
Feuth, Thijs
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10096-024-04776-0
- URN
-
urn:nbn:de:101:1-2406121204463.835565847043
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Feuth, Eeva
- Nieminen, Valtteri
- Palomäki, Antti
- Ranti, Juha
- Sucksdorff, Marcus
- Finnilä, Taru
- Oksi, Jarmo
- Vuorinen, Tytti
- Feuth, Thijs
- SpringerLink (Online service)
Other Objects (12)
Novel CD20 monoclonal antibodies for lymphoma therapy
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle
Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis
Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment
Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scidmice
The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody
Successful treatment of prolonged COVID-19 with Bamlanivimab in a patient with severe B-Cell aplasia due to treatment with an anti-CD20 monoclonal antibody : A case report
Prolonged viral suppression with anti-HIV-1 antibody therapy
Novel CD20 monoclonal antibodies for lymphoma therapy
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle
Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis
Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment
Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scidmice
The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody
Successful treatment of prolonged COVID-19 with Bamlanivimab in a patient with severe B-Cell aplasia due to treatment with an anti-CD20 monoclonal antibody : A case report
Prolonged viral suppression with anti-HIV-1 antibody therapy
Novel CD20 monoclonal antibodies for lymphoma therapy
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle
Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis
Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment
Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scidmice
The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody
Successful treatment of prolonged COVID-19 with Bamlanivimab in a patient with severe B-Cell aplasia due to treatment with an anti-CD20 monoclonal antibody : A case report